GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » Total Long-Term Liabilities

Edwards Lifesciences (WBO:EWLS) Total Long-Term Liabilities : €1,328 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Edwards Lifesciences Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Edwards Lifesciences's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was €1,328 Mil.

Edwards Lifesciences Total Long-Term Liabilities Historical Data

The historical data trend for Edwards Lifesciences's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Total Long-Term Liabilities Chart

Edwards Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,454.04 1,446.44 1,381.45 1,328.18 1,420.28

Edwards Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,323.97 1,279.88 1,275.55 1,420.28 1,328.21

Edwards Lifesciences Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Edwards Lifesciences Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » Total Long-Term Liabilities
Comparable Companies
DXCM STE PODD ZBH PEN MASI GMED BIO GKOS BRKR ABT BSX SYK MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 TSE:7733
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany EWL:Germany EWL:Germany E1WL34:Brazil
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences Headlines

No Headlines